The global pessary market is witnessing robust growth due to a significant rise in pelvic organ prolapse (POP) and urinary incontinence cases. A pessary is a non-surgical, intravaginal device designed to support the uterus, bladder, rectum, or vaginal walls in women suffering from POP or incontinence. With advancements in material technology and growing awareness around women’s health, the market is gaining considerable traction.
Ring pessaries, among the various product types available, remain the most widely used due to their ease of insertion, comfort, and ability to cater to different stages of prolapse and incontinence. This product segment continues to dominate due to its compatibility with a large percentage of female anatomies.
The preference for non-invasive alternatives over surgical interventions further boosts the adoption of pessaries. Many women, especially those who are physically unfit for surgery or wish to delay surgical correction, are choosing pessaries as their first-line treatment.
The COVID-19 pandemic also emphasized the role of pessaries as a temporary solution when elective surgeries were postponed. This led to greater adoption among patients and increased awareness among clinicians regarding their therapeutic value.
There is also considerable potential in emerging markets where awareness about pelvic organ prolapse is growing. Increasing investments in healthcare infrastructure and women’s health programs in regions such as South Asia and East Asia are anticipated to propel demand further.
Europe, led by Germany, is witnessing strong demand due to government-backed women’s health initiatives and an increased focus on non-invasive therapeutic options. The country’s healthcare infrastructure and lifestyle patterns also support market growth.
East Asia, with China at the forefront, shows the highest growth potential. China’s aging population and rising incidence of urinary incontinence are key factors boosting demand. Additionally, increased disposable income and better access to healthcare are supporting the uptake of pessary devices.
This product will be delivered within 1-3 business days.
Market Insights
According to recent market research, the pessary market is anticipated to grow from US$ 430 billion in 2025 to US$ 760 billion by 2032, reflecting a CAGR of 8.48% during the forecast period. A key factor contributing to this expansion is the increasing demand for conservative management options for POP and stress urinary incontinence, especially among the elderly female population.Ring pessaries, among the various product types available, remain the most widely used due to their ease of insertion, comfort, and ability to cater to different stages of prolapse and incontinence. This product segment continues to dominate due to its compatibility with a large percentage of female anatomies.
Key Drivers
A growing geriatric population worldwide is one of the primary drivers fueling market growth. Aging weakens the pelvic floor muscles, increasing the likelihood of prolapse and related complications. Additionally, lifestyle-associated diseases and multiple pregnancies contribute to pelvic floor disorders among younger women as well.The preference for non-invasive alternatives over surgical interventions further boosts the adoption of pessaries. Many women, especially those who are physically unfit for surgery or wish to delay surgical correction, are choosing pessaries as their first-line treatment.
The COVID-19 pandemic also emphasized the role of pessaries as a temporary solution when elective surgeries were postponed. This led to greater adoption among patients and increased awareness among clinicians regarding their therapeutic value.
Business Opportunity
The pessary market presents promising opportunities for manufacturers. The development of patient-specific and 3D-printed pessaries offers immense scope for innovation. Companies leveraging technologies such as cloud software, machine learning, and ultrasound to create customized pessary devices are expected to capitalize on this opportunity.There is also considerable potential in emerging markets where awareness about pelvic organ prolapse is growing. Increasing investments in healthcare infrastructure and women’s health programs in regions such as South Asia and East Asia are anticipated to propel demand further.
Regional Analysis
North America, particularly the United States, remains a significant revenue generator for pessary manufacturers. A high prevalence of POP, growing elderly female population, and advanced healthcare systems contribute to the region’s dominance.Europe, led by Germany, is witnessing strong demand due to government-backed women’s health initiatives and an increased focus on non-invasive therapeutic options. The country’s healthcare infrastructure and lifestyle patterns also support market growth.
East Asia, with China at the forefront, shows the highest growth potential. China’s aging population and rising incidence of urinary incontinence are key factors boosting demand. Additionally, increased disposable income and better access to healthcare are supporting the uptake of pessary devices.
Key Players
The pessary market is highly fragmented, with numerous global and regional manufacturers competing for market share. Key players operating in the global market include:
- CooperSurgical Inc.
- Bliss GVS Pharma
- MedGyn
- Panpac Medical Corporation
- Bioteque America
- Personal Medical Corporation
- Dr. Arabin GmbH & Co.
- Kangge Medical
- Integra Lifesciences
- Wallach Surgical Devices
- Medesign
Segmentation
By Product:
- Ring Pessaries
- Lever Pessaries
- Incontinence Rings
- Marland
- Gellhorn
- Gehrung
- Donuts
- Cubes
By Indication:
- Pelvic Organ Prolapse
- Urinary Incontinence
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Speciality Clinics
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Pessary Market Outlook, 2019-2032
4. North America Pessary Market Outlook, 2019-2032
5. Europe Pessary Market Outlook, 2019-2032
6. Asia Pacific Pessary Market Outlook, 2019-2032
7. Latin America Pessary Market Outlook, 2019-2032
8. Middle East & Africa Pessary Market Outlook, 2019-2032
9. Competitive Landscape
10. Appendix
Companies Mentioned
- CooperSurgical Inc
- Bliss GVS Pharma
- MedGyn
- Panpac Medical Corporation
- Bioteque America
- Personal Medical Corporation
- Dr.Arabin GmbH & Co.
- Kangge Medical
- Integra Lifesciences
- Wallach Surgical Devices
- Medesign
